| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Articles |
Third Department of Internal Medicine Semmelweis University, Faculty of Medicine, Budapest, Hungary. kalasz@kut.sote.hu
OBJECTIVE: Human fetuin/alpha(2)-HS-glycoprotein (AHSG) is a 49 kDa serum and tissue protein which is a natural inhibitor of insulin receptor signaling. We investigated serum AHSG levels during pregnancy and whether the protein is involved in insulin resistance observed in healthy pregnant women and patients with gestational diabetes. DESIGN: One hundred and four healthy pregnant women and 23 of their neonates, 30 patients with gestational diabetes and their neonates and 30 healthy age-matched non-pregnant females as a control group were investigated in a case-control cross-sectional study. METHODS: Serum AHSG was determined by radial immunodiffusion. RESULTS: We observed an increase of serum AHSG concentration in the second and third trimesters. Gestational diabetes patients had significantly higher AHSG levels than healthy pregnant women and non-pregnant controls. There was a highly significant positive correlation between serum AHSG concentration and indirect parameters of insulin resistance, i.e. tumor necrosis factor-alpha (TNF-alpha), leptin, C-peptide and C-peptide/blood glucose ratio. There was also a negative correlation between maternal AHSG, TNF-alpha, leptin levels and head circumference, body length and body weight of newborns. CONCLUSION: AHSG, TNF-alpha and leptin may contribute to insulin resistance during normal pregnancy and gestational diabetes. AHSG along with these cytokines may also negatively regulate neonatal skeletal development.
This article has been cited by other articles:
|
|
 |
|
  T. Reinehr and C. L. Roth Fetuin-A and Its Relation to Metabolic Syndrome and Fatty Liver Disease in Obese Children Before and After Weight Loss J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4479 - 4485. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Andersen, K. S. Burgdorf, T. Sparso, K. Borch-Johnsen, T. Jorgensen, T. Hansen, and O. Pedersen AHSG Tag Single Nucleotide Polymorphisms Associate With Type 2 Diabetes and Dyslipidemia: Studies of Metabolic Traits in 7,683 White Danish Subjects Diabetes, May 1, 2008; 57(5): 1427 - 1432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Stefan, A. M. Hennige, H. Staiger, J. Machann, F. Schick, S. M. Krober, F. Machicao, A. Fritsche, and H.-U. Haring {alpha}2-Heremans-Schmid Glycoprotein/ Fetuin-A Is Associated With Insulin Resistance and Fat Accumulation in the Liver in Humans Diabetes Care, April 1, 2006; 29(4): 853 - 857. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lavebratt, E. Dungner, and J. Hoffstedt Polymorphism of the AHSG gene is associated with increased adipocyte {beta}2-adrenoceptor function J. Lipid Res., October 1, 2005; 46(10): 2278 - 2281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Siddiq, F. Lepretre, S. Hercberg, P. Froguel, and F. Gibson A Synonymous Coding Polymorphism in the {alpha}2-Heremans-Schmid Glycoprotein Gene Is Associated With Type 2 Diabetes in French Caucasians Diabetes, August 1, 2005; 54(8): 2477 - 2481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Kalabay, E. Nemesanszky, A. Csepregi, M. Pusztay, K. David, G. Horvath, E. Ibranyi, L. Telegdy, A. Par, A. Biro, et al. Paradoxical alteration of acute-phase protein levels in patients with chronic hepatitis C treated with IFN-{alpha}2b Int. Immunol., January 1, 2004; 16(1): 51 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Jiang, M. Zhang, V. D. Wasem, J. J. Michal, H. Zhang, and R. W. Wright Jr Census of Genes Expressed in Porcine Embryos and Reproductive Tissues by Mining an Expressed Sequence Tag Database Based on Human Genes Biol Reprod, October 1, 2003; 69(4): 1177 - 1182. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
